Tolvaptan for Advanced or Refractory Heart Failure

Summary

This study will clarify the clinical usefulness of Tolvaptan therapy in patients with complicated acute decompensated heart failure and hyponatremia (low blood sodium).

Timeline

Start

2016-10

Primary completion

2020-06-30

Completion

2020-06-30

Outcome

Outcome not reported

Stopped (Enrollment): “Low accrual rate”

Drugs

Indications